medigraphic.com
ISSN 1561-297X (Print)

2012, Number 2

<< Back Next >>

Rev Cubana Estomatol 2012; 49 (2)

Antifungal effect of tinctures from propolis and pomegranate against species of Candida

Dantas DLF, Wanderley CY, Lira JR, de Oliveira LE, Dias DR

Language: Portugués
References: 24
Page: 99-106
PDF size: 47.02 Kb.


ABSTRACT

The use of natural products in Dentistry has been shown as an alternative source against oral diseases, including fungi infections, generally caused by Candida spp. The aim was to evaluate the antifungal action of tinctures from propolis (Apis milifera) and from pomegranate (Punica granatum) on Candida albicans (ATCC 76618), Candida krusei (ATCC 6538) and Candida tropicalis (ATCC 13803). The antifungal activity of tinctures was evaluated by Minimum Inhibitory Concentration method on Saburaud Dextrose Agar (Difco®). Six wells were confectioned, with 6 mm of diameter, to the insertion of 50 µL of tinctures. Six serial concentrations were evaluated, been 200 mg/mL the initial concentration for tincture from propolis and 300 mg/mL the initial concentration for tincture from pomegranate. Later, the Petri plates were incubated in bacteriological incubator for 48 h on 37 ºC. Data analysis for Minimum Inhibitory Concentration was conducted by measurement of inhibition zones, been considered inhibited when equal or bigger than 10 mm of diameter. For tincture from pomegranate, was verified that the Minimum Inhibitory Concentration on Candida albicans, Candida krusei and Candida tropicalis were 9.37 mg/mL, 9.37 mg/mL and 18.75 mg/mL, respectively. For tinctures from propolis, the antifungal action was verified only in pure concentration on Candida krusei and Candida tropicalis, but it was not observed on Candida albicans. The tinctures from pomegranate and propolis had antifungal activity on evaluated strains, except for tincture from propolis on Candida albicans.


REFERENCES

  1. Neville BW, Damm DD, Allem CM, Bouquot JE. Patologia oral e maxilofacial. São Paulo: Guanabara Koogan; 2009.

  2. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE. Practice guidelines for the treatment of candidiasis. J Infect Dis. 2000;30(4):662-78.

  3. Gabler IG. Incidence and anatomic localization of oral Candidiasis in patients with aids hospitalized in a public hospital in Belo Horizonte, MG, Brazil. J Appl Oral Sci Bauru. 2008;16(4):247-50.

  4. Gasparin AB. Prevalence of oral lesions in persons with HIV and associated factors in a southern Brazilian city. Cad Saúde Pública. 2009;25(6):1307-15.

  5. Siddiqui M, Khan AU. Antimicrobial activity of five herbal extracts against multi drug resistant (MRD) strains of bacteria and fungus of clinical origin. Molecules. 2009;14(2):586-97.

  6. Pozzatti P, Scheid LA, Spader TB, Atayde ML, Santurio JM, Alves SH. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp. Can J Microbiol. 2008;54(11):950-60.

  7. Khan R, Islam B, Akram M, Shakil S, Ahmad AA, Ali SM, et al. Antimicrobial activity of five herbal extracts against multi drug resistant (MRD) strains of bacteria and fungus of clinical origin. Molecules. 2009;14(2):586-97.

  8. Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W, et al. Contribution of mutations in the cytochrome P450 14á-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology. 1999;145(1):2701-13.

  9. Basso-Junior LR, Gast CE, Mao Y, Wong B. Fluconazole transport into Candida albicans Secretory Vesicles by the Membrane Proteins Cdr1p, Cdr2p, and Mdr1p. Eukaryotic Cell. 2010;9(6):960-70.

  10. Manoharlal R, Gorantala J, Sharma M, Dominique S, Prasad R. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans. Microbiology. 2010;156(1):313-26.

  11. White TC, Marr KA, Bowden RA. Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clinical Microbiology Reviews. 1998;11(2):382-402.

  12. Howell SA, Mallet AI, Noble WC. A comparison of the sterol content of multiple isolates of the Candida albicans. Darlington strain with other clinically azole-sensitive and resistant strains. J Appl Microbiol. 1990;69(5):692-6.

  13. Castro RD, Lima EO. Atividade antifúngica dos óleos essenciais de sassafrás (Ocotea odorifera Vell.) e alecrim (Rosmarinus officinalis L.) sobre o gênero Candida. Rev Bras Pl Med. 2011;13(2):203-8.

  14. Almeida LF, Cavalcanti YW, Viana WP, Lima EO. Screening da atividade antifúngica de Óleos Essenciais sobre Candida Albicans. Revista Brasileira de Ciências da Saúde. 2011;14(4):51-6.

  15. Silveira PF, Bandeira MAM, Arrais PSD. Farmacovigilância e reações adversas às plantas medicinais e fitoterápicas: uma realidade. Revista Brasileira de Farmacognosia. 2008;18(4):618-26.

  16. Cavalcanti YW, Almeida LDF, Padilha WWN. Anti-adherent activity of Rosmarinus officinalis essential oil on Candida albicans: an SEM analysis. Rev Odonto Cienc. 2011;26(2):139-44.

  17. Soares DGS, Olievira CB, Leal C, Drumond MRS, Padilha WWN. Susceptibilidade in vitro de bactérias bucais a tinturas fitoterápicas. Rev Odonto Ciênc. 2006;21(53):232-8.

  18. Almeida RVD, Castro RD, Pereira MSV, Paulo MQ, Santos JP, Padilha WWN. Efeito clínico de solução anti-séptica a base de própolis em crianças cárie ativas. Pesq Bras Odontop Clin Integr. 2006;6(1):87-92.

  19. Schreiner F. Uso do chá de Punica granatum (romã) no controle da aderência de bactérias orais em ligaduras ortodônticas. Robrac. 2009;18(45).

  20. Molina FP. Própolis, sálvia, calêndula e mamona-atividade antifúngica de extratos naturais sobre cepas de Candida albicans. Cienc Odontol Bras. 2008;11(2):86-93.

  21. Pereira JV, Pereira MSV, Sampaio FC, Sampaio MCC, Alves PM, Araújo CRF, et al. Efeito antibacteriano e antiaderente in vitro do extrato da Punica granatum Linn sobre microrganismos do biofilme dental. Rev Bras Farmacogn. 2006;16(1):88-93.

  22. Dias SMD, Gomes RT, Santiago WK, Paula AMB, Cortés ME, Santos VR. Antifungal activity of commercial ethanolic and aqueous extracts of Brazilian propolis against Candida spp. Rev Ciênc Farm Básica Apl. 2007;28(3):259-63.

  23. Nascimento GGF, Locatelli J, Freitas PC, Silva GL. Antibacterial activity of plant extracts and phytochemicals on antibiotic resistant bacteria. Braz J Microbiol. 2000;31(1):247-56.

  24. Holetz FB, Pessini GL, Sanches NR, Cortez DA, Nakamura CV, Dias Filho BP. Screening of some plants used in the brazilian folk medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz. 2002;97(7):1027.




2020     |     www.medigraphic.com